ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Lyndra Therapeutics to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference

November 16, 2021 GMT

WATERTOWN, Mass.--(BUSINESS WIRE)--Nov 16, 2021--

Lyndra Therapeutics, a clinical-stage biotechnology company working to make daily pills a thing of the past, today announced that members of its management team will present and host one-on-one meetings at the 33rd Annual Piper Sandler Virtual Healthcare Conference taking place November 30 through December 2, 2021.

An on-demand, pre-recorded presentation will be made available on the conference website starting on Monday, November 22, 2021 at 10:00 a.m. ET.

About Lyndra Therapeutics

Lyndra Therapeutics is pioneering ultra-long-acting oral therapies, which has never been done before. The company’s novel delivery system will allow people to take medicines once a week, or even less often, instead of every day. Their breakthrough oral capsule is designed to provide consistent drug levels for an entire week or as long as a month, from one, normal-sized capsule – something that has the potential to fundamentally change the way people take medicine. Lyndra’s robust pipeline is made up of therapies with established and well-known safety profiles across a number of disease areas in which non-adherence is known to be a significant driver of poor or undesirable outcomes, including central nervous system diseases, oral contraception and opioid use disorder, among others. Lyndra’s lead product candidate, weekly risperidone (LYN-005), is being developed for the treatment of people living with schizophrenia and bipolar 1 disorder. The company is also committed to advancing its platform across new chemical entities and a variety of critical global and public health opportunities alongside partners such as the Bill & Melinda Gates Foundation and the NIH. For more information, visit the company’s website at www.lyndra.com.

ADVERTISEMENT

View source version on businesswire.com:https://www.businesswire.com/news/home/20211116006394/en/

CONTACT: Investor Contact

Christopher Brinzey

ICR Westwicke

chris.brinzey@westwicke.com

339-970-2843

Media Contact

Dan Boyle

Orangefiery

ADVERTISEMENT

dan@orangefiery.com

(818) 209-1692

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Lyndra Therapeutics

Copyright Business Wire 2021.

PUB: 11/16/2021 05:11 PM/DISC: 11/16/2021 05:11 PM

http://www.businesswire.com/news/home/20211116006394/en